News

GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners

GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand…

2 years ago

Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Russell Kelley

Managing director of the Retinal Degeneration Fund joins board of directorsFORT WORTH, Texas, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Nacuity…

2 years ago

Ravkoo Health Joins Leading Healthcare Companies at HLTH 2022

HLTH Banner Ravkoo Health Joins Leading Healthcare Companies at HLTH 2022LAS VEGAS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Ravkoo Health,…

2 years ago

NeuroMetrix to Introduce Quell® Fibromyalgia at the American College of Rheumatology 2022 Annual Meeting

WOBURN, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) will introduce Quell Fibromyalgia at the American College…

2 years ago

Inovalon Announces 2022 Sustainability Report

Company ESG Report Highlights Achievements to Drive Sustainability and Commitment to Long Term VisionBOWIE, Md., Nov. 08, 2022 (GLOBE NEWSWIRE)…

2 years ago

Lexicon Pharmaceuticals Highlights Oral Presentation of Final Results From the RELIEF-DPN-1 Trial of LX9211 at the 16th Annual Pain Therapeutics Summit

Conference Call and Webcast at 5:00pm ET on November 14, 2022, Following the Oral PresentationTHE WOODLANDS, Texas, Nov. 08, 2022 (GLOBE…

2 years ago

Data Published in Peer-Reviewed Journal Demonstrate Protective Effects of Altamira’s Bentrio under Controlled Grass Pollen Exposure

HAMILTON, BERMUDA, Nov. 08, 2022 (GLOBE NEWSWIRE) -- • Publication in International Archives of Allergy and Immunology shows rapid onset…

2 years ago

ExCellThera announces 100th patient treated with UM171-expanded cell therapy

MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation,…

2 years ago

Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates

– $174.7 Million Cash and Cash Equivalents at September 30, 2022 – – Over 650 Patients Now Enrolled in Phase…

2 years ago

Novan to Report Third Quarter 2022 Financial Results on November 14, 2022

DURHAM, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it…

2 years ago